Figure 2.

Boceprevir plus PEG‐IFN/RBV: overall SVR rates and SVR rates according to prior responses in treatment‐experienced subjects. Overall, the SVR rates were significantly higher for patients receiving a boceprevir‐containing regimen versus patients receiving PEG‐IFN and RBV (59% and 66% versus 21%). The response was dependent on the prior response, with prior relapsers responding better than prior partial responders. Adapted with permission from New England Journal of Medicine.17 RGT means response guided therapy. PR48 means pegylated interferon and ribavirin taken for 48 weeks.